The US District Court for the District of Delaware erred in allowing the French headquarters to escape the suit early and in its claim construction that led to the invalidation of two UMass patents for treating skin with the organic compound adenosine, the US Court of Appeals for the Federal Circuit ruled in a precedential opinion. L’Oreal must now defend against the infringement suit ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.